Patents by Inventor Lori Sutin

Lori Sutin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aryl sulfonamide compounds for treating obesity
    Patent number: 7718650
    Abstract: The present invention relates to substituted bis-arylsulfonamide and arylsulfonamide compounds of the general formula (I) or the formula (II), which compounds are potentially useful for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes and/or disorders of the central nervous system.
    Type: Grant
    Filed: December 19, 2007
    Date of Patent: May 18, 2010
    Assignee: Biovitrum AB
    Inventors: Ulf Bremberg, Patrizia Caldirola, Annika J. Jensen, Gary Johansson, Lori Sutin, Andrew Mott, Jan Tejbrant
  • Substituted azole aromatic heterocycles as inhibitors of 11?-HSD-1
    Patent number: 7666888
    Abstract: Compounds of formula I and IV are described and have therapeutic utility, particularly in the treatment of diabetes, obesity and related conditions and disorder: wherein the variables A-B, R1, R2, m, and Q are described herein.
    Type: Grant
    Filed: July 18, 2007
    Date of Patent: February 23, 2010
    Assignees: Amgen Inc., Biovitrum AB
    Inventors: Michael D. Bartberger, Christopher H. Fotsch, Martin Haraldsson, David St. Jean, Lars Johansson, Marianne Nilsson, Lori Sutin, Katrina Flyrén
  • Substituted sulphonamide compound and uses thereof
    Patent number: 7582767
    Abstract: The present invention relates to compounds of the formula (I), wherein R1 and R2 are as defined in the description; to pharmaceutical formulations comprising these compounds, and to the use of the compounds for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes, and/or CNS disorders, to achieve reduction of body weight and/or body weight gain.
    Type: Grant
    Filed: June 5, 2006
    Date of Patent: September 1, 2009
    Assignee: Biovitrum AB (publ.)
    Inventors: Patrizia Caldirola, Gary Johansson, Lori Sutin
  • Substituted sulfonamide compounds useful for the prophylaxis and treatment of conditions relating to obesity, type II diabetes and/or disorders of the central nervous system
    Patent number: 7566715
    Abstract: The present invention relates to substituted bis-arylsulfonamide and arylsulfonamide compounds of the general formula (I) or the formula (II), which compounds are potentially useful for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes and/or disorders of the central nervous system.
    Type: Grant
    Filed: August 30, 2005
    Date of Patent: July 28, 2009
    Assignee: Biovitrum AB
    Inventors: Ulf Bremberg, Patrizia Caldirola, Annika J. Jensen, Gary Johansson, Lori Sutin, Andrew Mott, Jan Tejbrant
  • NEW COMPOUNDS
    Publication number: 20080096873
    Abstract: The present invention relates to substituted bis-arylsulfonamide and arylsulfonamide compounds of the general formula (I) or the formula (II), which compounds are potentially useful for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes and/or disorders of the central nervous system.
    Type: Application
    Filed: December 19, 2007
    Publication date: April 24, 2008
    Inventors: Ulf Bremberg, Patrizia Caldirola, Annika Jensen, Gary Johansson, Lori Sutin, Andrew Mott, Jan Tejbrant
  • Compounds
    Publication number: 20080039450
    Abstract: The present invention relates to compounds of the general formula I wherein X, Y, Z, A, Ar, R1, R2, R3, and R4 are as defined herein, which compounds are inhibitors of MNK2 and MNK1. The invention also relates to the use of the compounds in therapy, pharmaceutical compositions comprising the compounds, and the use of the compounds for the preparation of a medicament for the prophylaxis and treatment of disorders related to undesired activity of MNK1 and/or MNK2 kinases.
    Type: Application
    Filed: June 21, 2007
    Publication date: February 14, 2008
    Inventors: Annika Jensen, Rune Ringom, Carmen Medina, John Vock, Marie Wiik, Tobias Koolmeister, Johan Angbrant, Martin Henriksson, Teresa Sandvall, Lori Sutin, Lars Johannson, Bjorn Nilsson
  • SUBSTITUTED AZOLE AROMATIC HETEROCYCLES AS INHIBITORS OF 11BETA-HSD-1
    Publication number: 20080021022
    Abstract: Compounds of formula I and IV are described and have therapeutic utility, particularly in the treatment of diabetes, obesity and related conditions and disorder: wherein the variables A-B, R1, R2, m, and Q are described herein.
    Type: Application
    Filed: July 18, 2007
    Publication date: January 24, 2008
    Inventors: Michael Bartberger, Christopher Fotsch, Martin Haraldsson, David St. Jean, Lars Johansson, Marianne Nilsson, Lori Sutin, Katrina Flyren
  • Compounds
    Patent number: 7319097
    Abstract: The present invention relates to substituted bis-arylsulfonamide and arylsulfonamide compounds of the general formula (I) or the formula (II), which compounds are potentially useful for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes and/or disorders of the central nervous system
    Type: Grant
    Filed: August 30, 2005
    Date of Patent: January 15, 2008
    Assignee: Biovitrum AB
    Inventors: Ulf Bremberg, Patrizia Caldirola, Annika J. Jensen, Gary Johansson, Lori Sutin, Andrew Mott, Jan Tejbrant
  • Arylsulfonamide compounds
    Patent number: 7173035
    Abstract: The present invention relates to substituted bis-arylsulfonamide and arylsulfonamide compounds of the general formula (I) or the formula (II), which compounds are potentially useful for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes and/or disorders of the central nervous system.
    Type: Grant
    Filed: May 10, 2002
    Date of Patent: February 6, 2007
    Assignee: Biovitrum AB
    Inventors: Ulf Bremberg, Patrizia Caldirola, Annika J. Jensen, Gary Johansson, Lori Sutin, Andrew Mott, Jan Tejbrant
  • Compounds
    Publication number: 20060293361
    Abstract: The present invention relates to compounds of the formula (I), wherein R1 and R2 are as defined in the description; to pharmaceutical formulations comprising these compounds, and to the use of the compounds for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes, and/or CNS disorders, to achieve reduction of body weight and/or body weight gain.
    Type: Application
    Filed: June 5, 2006
    Publication date: December 28, 2006
    Inventors: Patrizia Caldirola, Gary Johansson, Lori Sutin
  • New compounds
    Publication number: 20060009446
    Abstract: The present invention relates to substituted bis-arylsulfonamide and arylsulfonamide compounds of the general formula (I) or the formula (II), which compounds are potentially useful for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes and/or disorders of the central nervous system.
    Type: Application
    Filed: August 30, 2005
    Publication date: January 12, 2006
    Inventors: Ulf Bremberg, Patrizia Caldirola, Annika Jensen, Gary Johansson, Lori Sutin, Andrew Mott, Jan Tejbrant
  • New compounds
    Publication number: 20050288275
    Abstract: The present invention relates to substituted bis-arylsulfonamide and arylsulfonamide compounds of the general formula (I) or the formula (II), which compounds are potentially useful for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes and/or disorders of the central nervous system.
    Type: Application
    Filed: August 30, 2005
    Publication date: December 29, 2005
    Inventors: Ulf Bremberg, Patrizia Caldirola, Annika Jensen, Gary Johansson, Lori Sutin, Andrew Mott, Jan Tejbrant
  • Compounds
    Patent number: 6969710
    Abstract: The present invention relates to substituted bis-arylsulfonamide and arylsulfonamide compounds of the general formula (I) or the formula (II), which compounds are potentially useful for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes and/or disorders of the central nervous system.
    Type: Grant
    Filed: May 13, 2002
    Date of Patent: November 29, 2005
    Assignee: Biovitrum AB
    Inventors: Ulf Bremberg, Patrizia Caldirola, Annika J. Jensen, Gary Johansson, Andrew Mott, Lori Sutin, Jan Tejbrant
  • New compounds
    Publication number: 20030149019
    Abstract: The present invention relates to substituted bis-arylsulfonamide and arylsulfonamide compounds of the general formula (I) or the formula (II), which compounds are potentially useful for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes and/or disorders of the central nervous system.
    Type: Application
    Filed: May 10, 2002
    Publication date: August 7, 2003
    Inventors: Ulf Bremberg, Patrizia Caldirola, Annika J. Jensen, Gary Johansson, Lori Sutin, Andrew Mott, Jan Tejbrant
  • New compounds
    Publication number: 20030149020
    Abstract: The present invention relates to substituted bis-arylsulfonamide and arylsulfonamide compounds of the general formula (I) or the formula (II), which compounds are potentially useful for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes and/or disorders of the central nervous system.
    Type: Application
    Filed: May 13, 2002
    Publication date: August 7, 2003
    Inventors: Ulf Bremberg, Patrizia Caldirola, Annika J. Jensen, Gary Johansson, Andrew Mott, Lori Sutin, Jan Tejbrant